Sight Sciences, Inc. (SGHT): Capital Expenditures

Annual figures by period end, from SEC filings.

$224.0K
Year ended 2025-12-31
$93.0K
Trailing 12 months to 2026-06-30
-38.6%
3-year compound annual growth
-25.1%
5-year compound annual growth
$970.0K2020-12-31: $953.0K2021-12-31: $813.0K2022-12-31: $970.0K2023-12-31: $791.0K2024-12-31: $385.0K2025-12-31: $224.0K$224.0K
2020-12-31 Capital Expenditures (USD) 2025-12-31
Period endedCapital ExpendituresChange YoYSource filing
2025-12-31$224.0K-41.8%2026-03-04, From 2025-01-01
2024-12-31$385.0K-51.3%2026-03-04, From 2024-01-01
2023-12-31$791.0K-18.5%2025-03-07, From 2023-01-01
2022-12-31$970.0K+19.3%2024-03-13, From 2022-01-01
2021-12-31$813.0K-14.7%2023-03-16, From 2021-01-01
2020-12-31$953.0Kn/a2022-03-24, From 2020-01-01

Capital Expenditures at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCapital ExpendituresChange YoY
Sight Sciences, Inc. (SGHT)2025-12-31$224.0K-41.8%
PRO DEX Inc (PDEX)2026-06-30$483.0K-61.2%
TELA Bio, Inc. (TELA)2025-12-31$448.0K-54.7%
AVITA Medical, Inc. (RCEL)2025-12-31$1.00M-89.0%
Iradimed Corp (IRMD)2025-12-31$7.76M-3.0%
Delcath Systems, Inc. (DCTH)2025-12-31$1.55M+176.7%
Pulmonx Corp (LUNG)2025-12-31$452.0K-68.8%
Kestra Medical Technologies, Ltd. (KMTS)2026-04-30$34.89M+52.1%
Meihua International Medical Technologies Co., Ltd. (MHUAF)2025-12-31$15.6K-88.3%

Compare SGHT, PDEX, TELA, RCEL side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗